Article
A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins.
Scientific reports - 15 Feb 2022
Shishido Hideki, Yoon Jae Seok, Skach William R
Abstract excerpt
Genetic mutations cause a wide spectrum of human disease by disrupting protein folding, both during and after synthesis. Transient de-novo folding intermediates therefore represent potential drug targets for pharmacological correction of protein folding disorders. Here we develop a FRET-based high-throughput screening (HTS) assay in 1,536-well format capable of identifying small molecules that interact with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
